sacituzumab
gilead
[' sg ', 'gbm']
 phase ii mc1774- 18fdopa- prt/mri for tumor delineation and proton therapy for gbm in elderly n=43 median age 70.2 / 23% more inclusion of missed tumor areas with pet x mri/ sg 12.9 m (25 m mgmt met).saga trial is ongoing abstract 2002 vora et al. #asco2023 
Medical Oncology  MD, MSc, PhD (Thoracic and Neuroncology)